The Marvell NVIDIA trillion-dollar endorsement that detonated on June 2 sent MRVL up more than 32% in a single session, pushing the stock to all-time highs near $291 and swelling its market cap to roughly $240 billion overnight. The catalyst: Jensen Huang made a surprise appearance at Marvell CEO Matt Murphy’s Computex keynote in Taipei, joining Murphy on stage for about 10 minutes and calling Marvell the “next trillion-dollar company.”
| Metric | Value |
|---|---|
| MRVL session gain (June 2) | +32.5% |
| Q1 FY2027 total revenue | $2.418B (record, +28% YoY) |
| Data center revenue share | ~76% of total |
| FY2028 revenue target | $16.5B |
| Q2 FY2027 guidance | ~$2.7B (~35% YoY growth) |
| Institutional ownership | 83.5% of float |
Ten Minutes That Moved $70 Billion
The Marvell keynote was scheduled for 10:30 a.m. local time at the Taipei Nangang Exhibition Center. Murphy used it to frame connectivity as the defining constraint in AI scaling, calling Marvell the “undisputed connectivity leader” and, pointedly, “the Switzerland of the industry” — a neutrality pitch aimed squarely at hyperscalers wary of vendor lock-in. According to Semicon Alpha’s keynote transcript, Murphy argued AI scaling is “fundamentally a connectivity challenge” and laid out a portfolio spanning coherent optics between data centers, PAM-4 and Ethernet switching inside them, copper SerDes inside the rack, and die-to-die interfaces inside the package.
Then Huang walked out. The moment reframed the Marvell NVIDIA trillion-dollar endorsement from marketing to strategy. Huang’s appearance came roughly three months after NVIDIA’s $2 billion investment in Marvell, structured as Series A convertible preferred stock. That same investment pattern has been deployed by NVIDIA toward Synopsys, CoreWeave, Coherent, Lumentum, and Nebius Group in recent months, but the on-stage validation at Computex put Marvell in a different category.
Marvell NVIDIA Trillion-Dollar Endorsement Meets a Record Quarter
The endorsement landed on top of already strong numbers. Marvell’s Q1 FY2027 filing showed total net revenue of $2.418 billion, a company record, up 28% year-over-year and 9% sequentially, beating the midpoint of management’s own guidance by $18 million. Data center revenue hit $1.83 billion, roughly 76% of the total.
Management followed with guidance that priced in continued acceleration. Q2 FY2027 revenue is targeted at roughly $2.7 billion, implying approximately 35% year-over-year growth. Full fiscal year 2027 revenue is expected to reach nearly $11.5 billion, a 40% jump from the prior year. The FY2028 target was lifted to $16.5 billion, a $1.5 billion increase from prior guidance, according to TIKR’s earnings analysis.
One number that complicates the story: net income dropped to $34.5 million from $177.9 million in the year-ago period. The culprit was a $331.8 million increase in the contingent consideration liability tied to the Celestial AI acquisition, which closed during or before the quarter at a price of $3.5 billion. Marvell also absorbed a $469 million acquisition of XConn and issued $1.0 billion in 2036 senior notes. The balance sheet ended the quarter with $3.8 billion in cash after repaying $500 million of 2026 notes. Acquisition drag on reported earnings is real, but the market is clearly pricing non-GAAP metrics and revenue trajectory rather than the GAAP bottom line.
Options Mechanics and Valuation
The Marvell NVIDIA trillion-dollar endorsement triggered classic gamma-squeeze mechanics. Aggressive call buying forced market makers to buy underlying shares as a hedge, compounding the move. Short sellers, whose volume had risen 14% over the prior month to roughly 3.6% of float, were effectively run over. Bearish put positions clustered between $122 and $200 were liquidated as the stock blew through those levels.
Institutional holders own 83.5% of shares, a base that tends to absorb volatility rather than amplify it. Insider selling topped $32 million over the trailing three months, but those transactions were executed under pre-scheduled 10b5-1 plans, limiting any read-through on executive conviction.
Valuation is not cheap. The stock trades above 90x forward earnings and roughly 13x book. Barclays and Roth Capital have both raised price targets toward the $275-$300 range, which the stock has now traded through. The consensus average of $215 sits far below the current price, meaning analyst targets will need to catch up or the stock will need a pullback to find support.
The next binary is Q2 FY2027 results against that $2.7 billion revenue target. Execution there either validates the trillion-dollar thesis or tests how much air is in the multiple.
